Back to my future: life after surgery for tertiary hyperparathyroidism
- PMID: 39551899
- DOI: 10.1007/s00423-024-03539-x
Back to my future: life after surgery for tertiary hyperparathyroidism
Abstract
Purposes: Evaluate the changes in quality of life (QoL) in patients affected by tertiary hyperparathyroidism (THPT) after surgical treatment using the Parathyroidectomy Assessment of Symptoms (PAS) and Short Form-36 (SF-36) questionnaires.
Methods: Single centre longitudinal retrospective, single-institution analysis of 34 patients with THPT and submitted to parathyroidectomy between 2015 and 2021. The PAS and SF-36 questionnaires were administered before surgery and 24 months after discharge.
Results: A significative QoL amelioration was registered in physical SF-36 (42.4 ± 11.7 vs 56.7 ± 9.2; P < 0.001), mental SF-36 (47.3 ± 12.1 vs 61.8 ± 7.9; P < 0.001) and PAS score (582 ± 163 vs 293 ± 141; P < 0.001) with a significative improvement of all the 13 symptoms considered. We found that pre-operative intact parathormone (iPTH) levels, preoperative T-score and time of haemodialysis before RTX were predictors of both PAS and SF-36 mental score modifications. A positive correlation was also fund between pre-operative PAS values and their post operative cutback.
Conclusions: Parathyroidectomy for THPT brings to a concrete amelioration of all the disease-related and nonspecific symptoms with significative improvement of QoL. To develop a tailored approach of every patient's needs, from diagnosis to future treatment, we suggest to introduce the symptoms assessment scale as standard stage in periodic evaluations.
Keywords: Parathyroidectomy; Parathyroidectomy assessment of symptoms; Quality of life; Short Form-36; Tertiary hyperparathyroidism.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
References
-
- Darbà J, Marsà A (2020) Epidemiology and management of parathyroid gland disordersin Spain over 15 years: a retrospective multicentre analysis. PLoS ONE 15(3). https://doi.org/10.1371/journal.pone.0230130
-
- Sutton W, Chen X, Patel P, Karzai S, Prescott J, Segev D et al (2022) Prevalence and riskfactors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 171(1):69–76. https://doi.org/10.1016/j.surg.2021.03.067 - DOI - PubMed
-
- Palumbo VD, Palumbo VD, Damiano G, Messina M, Fazzotta S, Lo Monte G et al (2021) Tertiary hyperparathyroidism: a review. Clin Ter 172(3):241–246 - PubMed
-
- Goltzman D, Feingold RK, Anawalt B, Boyce A, Chrousos G (2000–2019) Approach to hypercalcemia. In: Endotext. MDText.com, INC., South Dartmouth
-
- Thippaiah SM, Fargason RE, Gude JG, Muralidhara SN, Birur B (2020) Lithium-associated hyperparathyroidism followed by catatonia. AACE Clin Case Rep 7(3):189–191. https://doi.org/10.1016/j.aace.2020.12.010 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
